NCT03281759

Brief Summary

The purpose of this study is to evaluate early and delayed effects of Transcranial LED Therapy (TCLT) and determinate whether this therapy is effective for cognitive rehabilitation of Diffuse Axonal Injury patients after Traumatic Brain Injury.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2017

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 4, 2017

Completed
9 days until next milestone

First Posted

Study publicly available on registry

September 13, 2017

Completed
18 days until next milestone

Study Start

First participant enrolled

October 1, 2017

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2018

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2018

Completed
Last Updated

September 13, 2017

Status Verified

August 1, 2017

Enrollment Period

1 year

First QC Date

September 4, 2017

Last Update Submit

September 11, 2017

Conditions

Keywords

Brain Injuries, Traumatic;Diffuse Axonal InjuryLow-Level Light TherapyNeurologic ManifestationsQuality of LifeRehabilitation

Outcome Measures

Primary Outcomes (1)

  • Improvement of early and delayed functional outcome measured by Glasgow Outcome Scale Extended (GOSE).

    Evaluation of improvement of early and delayed functional outcome measured by Glasgow Outcome Scale Extended (GOSE) after stimulation in comparison to the placebo group.

    Before stimulation and 1, 3 and 6 months after first stimulation

Secondary Outcomes (2)

  • Improvement effects of transcranial LED in followup images measured by Marshall computed tomography scale and Adams grading scale for diffuse axonal injury.

    Before stimulation and 1, 3 and 6 months after first stimulation

  • Hemodynamic improvement effect of transcranial LED measured by transcranial doppler (systolic and diastolic velocity of the left middle cerebral and basilar arteries, and the pulsatility index and resistance index values).

    Before stimulation and 1, 3 and 6 months after first stimulation

Study Arms (2)

Active Coil Helmet

ACTIVE COMPARATOR

The patients will undergo 18 sessions (627 nm, 70 mW/cm2, 10 J/cm2) at four points of the frontal and parietal region for 30 s each, totaling 120 s three times per week for 6 weeks, lasting 30 minutes of transcranial LED stimulation.

Device: Transcranial LED Therapy (Active coil helmet)

Inactive Coil Helmet

PLACEBO COMPARATOR

The patients assigned to this group will undergo 18 sessions of transcranial LED but with an inactive coil, which will not generate LED emissions.

Device: Transcranial LED Therapy (Inactive coil helmet)

Interventions

The patients will undergo 18 sessions of repetitive transcranial LED stimulation.

Active Coil Helmet

The patients assigned to this group will undergo 18 sessions of transcranial LED but with an inactive coil, which will not generate LED emissions, only a similar red light color.

Inactive Coil Helmet

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • \) Patient victims of Traumatic Brain Injury with Glasgow Coma Scale ≤8 on admission:
  • Head CT scan showing diffuse axonal lesion.
  • CT scan without focal surgical lesions (Marshall I and II) and no signs of intracranial hypertension.
  • Transcranial Doppler and optic nerve sheath US with no signs of intracranial hypertension.
  • Admission less than 8 hours of trauma.

You may not qualify if:

  • History of drug or narcotic abuse.
  • Emergence of surgical lesions or signs of intracranial hypertension in followup CTs.
  • Transcranial Doppler or optic nerve sheath US presenting signs of intracranial hypertension.
  • Psychiatric disorders.
  • Injury severity score ≥3, according to the Abbreviated Injury Scale

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Sao Paulo General Hospital

São Paulo, São Paulo, 05401-000, Brazil

RECRUITING

Related Publications (1)

  • Santos JGRPD, Zaninotto ALC, Zangaro RA, Carneiro AMC, Neville IS, de Andrade AF, Teixeira MJ, Paiva WS. Effects of transcranial LED therapy on the cognitive rehabilitation for diffuse axonal injury due to severe acute traumatic brain injury: study protocol for a randomized controlled trial. Trials. 2018 Apr 24;19(1):249. doi: 10.1186/s13063-018-2632-5.

MeSH Terms

Conditions

Brain Injuries, DiffuseBrain Injuries, TraumaticDiffuse Axonal InjuryNeurologic Manifestations

Condition Hierarchy (Ancestors)

Brain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and InjuriesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Wellingson S Paiva, PhD

    University of Sao Paulo General Hospital

    STUDY CHAIR
  • Joao G Santos, MD

    University of Sao Paulo General Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Wellingson S Paiva, PHD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 4, 2017

First Posted

September 13, 2017

Study Start

October 1, 2017

Primary Completion

October 1, 2018

Study Completion

December 1, 2018

Last Updated

September 13, 2017

Record last verified: 2017-08

Locations